4/5/16 17:06 | 4/2/16 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | EVP,Chie | M.d | 0 | 0.00 | 33 | 1 | 45 | 3 | D | -15 | -36 | -8 | -14 | -1 | 2 | 3 | 4 | 5 | 0 | 3 | -8 | 18 | 3 |
2/25/16 17:07 | 2/23/16 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 0 | 6 | 3 | D | -26 | -36 | -8 | -11 | -8 | -5 | 4 | -2 | 1 | 4 | -3 | 4 | 22 | 9 |
2/17/16 17:54 | 2/12/16 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 1 | 76 | 2 | D | -22 | -35 | -18 | -12 | -13 | -1 | -6 | 2 | -2 | -3 | -6 | 0 | 19 | 8 |
4/3/15 16:24 | 4/2/15 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 1 | 139 | 2 | D | 111 | 33 | 27 | 22 | 1 | 0 | -9 | -4 | 1 | 3 | -7 | -2 | -31 | -36 |
2/17/15 20:50 | 2/12/15 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 1 | | 1 | D | 136 | 19 | 16 | 22 | 15 | 8 | 0 | -1 | 1 | 3 | 7 | -2 | -22 | -36 |
12/16/14 16:36 | 12/15/14 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | S | -686 | 346.50 | 33 | -2 | -85 | 0 | D | 122 | 22 | 10 | 3 | 5 | 9 | -2 | -2 | 2 | 8 | 4 | 31 | 20 | -11 |
4/3/14 16:27 | 4/2/14 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 1 | 77 | 2 | D | 145 | 58 | 26 | 11 | -8 | -7 | -1 | 5 | -4 | 0 | -6 | 9 | 7 | 36 |
2/14/14 16:45 | 2/12/14 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Artavanis-Tsakonas Spyridon | MA | O | SVP,Chie | M.d | 0 | 0.00 | 33 | 1 | 72 | 2 | D | 178 | 98 | 55 | 39 | 17 | 8 | 7 | 3 | 2 | 6 | 5 | -12 | 3 | 19 |